Geisinger’s Genomics and Precision Health Initiative, Part II

John Bulger, DO, MBA, Chief Medical Officer Population Health, Geisinger Health System and Chief Medical Officer of Geisinger Health Plan, and David Ledbetter, PhD, FACMG, Executive VP & Chief Scientific Officer, Geisinger Health System.  After extensive experience with DNA sequencing of patient-participants in a research setting, Geisinger has initiated clinical DNA sequencing in three primary care clinics throughout our system.  Nearly 1,000 patients have had sequencing performed, and 3% are found to have a genomic change putting them at significantly increased risk for early onset cancers (e.g., breast, ovarian, colon, or cardiovascular disease, i.e., familial hypercholesterolemia). Genetic counselors partner with these high-risk patients and their primary care physicians to seek risk-reducing actions or procedures. Drs. Bulger and Ledbetter will share their “lessons learned” from this primary care patient management approach.  (Part I was September 25, 2018, and can be accessed via our teleconference library.)